Avinger (NASDAQ:AVGR) Now Covered by StockNews.com

Investment analysts at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR) in a report issued on Thursday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Price Performance

AVGR stock opened at $0.90 on Thursday. Avinger has a 1 year low of $0.83 and a 1 year high of $6.55. The company has a market cap of $1.54 million, a P/E ratio of -0.05 and a beta of 1.17. The firm has a 50-day moving average of $1.07 and a 200 day moving average of $2.05.

Avinger (NASDAQ:AVGR) last announced its earnings results on Thursday, August 8th. The medical device company reported ($2.82) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.43) by ($2.39). The business had revenue of $1.85 million for the quarter, compared to analyst estimates of $2.55 million. On average, equities research analysts expect that Avinger will post -4.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Avinger

A hedge fund recently bought a new stake in Avinger stock. Armistice Capital LLC bought a new position in Avinger, Inc. (NASDAQ:AVGR) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 43,747 shares of the medical device company’s stock, valued at approximately $81,000. Armistice Capital LLC owned about 2.57% of Avinger at the end of the most recent quarter. 18.30% of the stock is currently owned by institutional investors.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.